Biol Reprod Keystone Symposia Conference on Frontiers in Reproductive Biology & Regulation of Fertility.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print March 17, 2004.
Biol Reprod 2004, 10.1095/biolreprod.103.023549
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
71/1/199    most recent
biolreprod.103.023549v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roberts, R.
Right arrow Articles by Hardy, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roberts, R.
Right arrow Articles by Hardy, K.
Agricola
Right arrow Articles by Roberts, R.
Right arrow Articles by Hardy, K.
BIOLOGY OF REPRODUCTION 71, 199–209 (2004)
DOI: 10.1095/biolreprod.103.023549
© 2004 by the Society for the Study of Reproduction, Inc.


Gamete Biology

Energy Substrate Metabolism of Mouse Cumulus-Oocyte Complexes: Response to Follicle-Stimulating Hormone Is Mediated by the Phosphatidylinositol 3-Kinase Pathway and Is Associated with Oocyte Maturation1

Ruth Roberts3, Jaroslav Stark4, Aikaterini Iatropoulou3, David L. Becker5, Stephen Franks3, and Kate Hardy2,3

Institute of Reproductive and Developmental Biology,3 Imperial College London, Hammersmith Hospital, London W12 0NN, United Kingdom Department of Mathematics,4 Imperial College London, London SW7 2AZ, United Kingdom Department of Anatomy and Developmental Biology,5 University College London, London WC1E 6BT, United Kingdom


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Successful in vitro maturation (IVM) of oocytes obtained from medium-sized antral follicles could avoid the need for superovulation for in vitro fertilization. The wide range of doses of FSH used in IVM prompted us to study the effect of varying concentrations of FSH on the dynamics of nutrient uptake and production by individual maturing mouse cumulus-oocyte complexes (COCs). COCs isolated from the antral follicles of unprimed, prepubertal B6CBF1 mice were cultured individually in increasing concentrations of FSH (0–2000 ng/ml). Following culture, pyruvate, glucose, and lactate uptake or production by individual complexes were noninvasively assessed and compared with the stage of nuclear maturation of the enclosed oocyte. FSH significantly increased oocyte maturation and produced a two- to threefold increase in glucose uptake and lactate production by COCs in which the enclosed oocyte completed maturation. In these COCs, pyruvate was taken up under control conditions but was produced in progressively higher quantities in increasing concentrations of FSH. In COCs where the oocyte failed to complete maturation, pyruvate was taken up (rather than produced) and glucose uptake and lactate production were lower and unaffected by the presence or absence of FSH. This suggests that there is dialogue between cumulus cells and the maturing oocyte that influences FSH responsiveness and substrate metabolism of the whole COC. Finally, inhibition of FSH-stimulated glucose uptake by the PI3-kinase inhibitor LY294002 and the finding of GLUT4 protein in granulosa cells suggest that FSH increases glucose uptake by PI3-kinase-mediated translocation of GLUT4 to the granulosa cell membrane.

cumulus cells, follicle-stimulating hormone, gamete biology, meiosis, oocyte development


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Follicle stimulating hormone (FSH) plays a central role in the regulation of follicle growth and survival [1], acting through FSH receptors expressed exclusively in granulosa cells [2]. Its importance for in vivo follicle development is clearly demonstrated in the absence of circulating FSH or competent FSH receptors, where follicle maturation is impaired and ovulation fails [3, 4]. There is increasing evidence that FSH also plays a role in the resumption of meiosis [57]. Exogenous FSH is routinely used to increase follicle recruitment, producing supernumerary oocytes in rodents, humans, and domestic species during cycles of in vitro fertilization. It is also commonly added to the culture media used for the in vitro maturation of oocytes.

When oocytes and their associated cumulus cells are removed from the follicular environment, spontaneous maturation occurs [8, 9]. This approach is now commonly used for the in vitro maturation of oocytes in domestic species and is stimulating considerable interest as an approach for increasing the number of oocytes available for human-assisted reproduction [10]. As subsequent development of in vitro-matured oocytes is generally compromised [1012], gonadotropins are routinely added to the culture medium to augment maturation [10, 13] and provide oocytes that are more developmentally competent [1318]. However, with no clear consensus on the optimum concentration of FSH needed, there is considerable variation in the dose range used (10 IU eCG/ml or 10–75 mIU eCG/ml–1 human menopausal gonadotropin for human in vitro maturation [IVM]; 10–1000 ng/ml or 0.2 IU eCG/ml–1 FSH for mouse IVM) [10, 16, 1921]. Even following maturation in the presence of gonadotropins, live birth rates remain low. The decreased developmental competence of oocytes matured in vitro highlights the importance of the maturation environment in the production of healthy oocytes.

In the antral follicle, FSH alters the environment of the maturing oocyte by stimulating granulosa cell division and differentiation [4], modulating steroidogenesis [15, 22, 23], granulosa cell metabolism [24, 25], and protein synthesis [7, 22] and inducing cumulus expansion [26]. At this time, the oocyte is undergoing critical cellular events that enable the egg to resume meiosis and complete cytoplasmic maturation, raising concerns about possible deleterious effects of elevated levels of FSH. Indeed, animal studies have shown that exogenous gonadotropins (superovulation) can have a detrimental effect on both preimplantation [22, 27 30] and postimplantation development [27, 3036]. Collectively, these studies suggest that exposure to high levels of FSH in vivo may have an adverse effect on follicular function and oocyte health and prompted us to examine the effects of varying doses of FSH in vitro on the maturation of mouse oocytes, using energy substrate uptake and production as a marker of the health of the cumulus-oocyte complex.

Our aim in this study was to ascertain whether increasing concentrations of FSH alter the nutritional environment of the maturing oocyte by changing uptake and production of the energy substrates pyruvate, glucose, and lactate by murine cumulus-oocyte complexes (COCs). Pyruvate, as an energy source, is obligatory for resumption of meiosis [37, 38] and is supplied by surrounding cumulus cells through the glycolysis of glucose [39, 40]. Levels of these energy substrates can have a profound effect on oocyte maturation [41], and adequate levels of pyruvate and glucose are important for progression to metaphase II [19, 42]. Cumulus-enclosed oocytes can be prevented from undergoing spontaneous maturation using inhibitory agents such as cyclic AMP and purines [5, 6]. FSH overcomes this inhibition, resulting in ligand-induced maturation [6]. The hypoxanthine-arrested cumulus-enclosed oocyte model has been used to study the role of FSH in modulating substrate metabolism and resumption of meiosis [6, 24, 25, 43] and has demonstrated, for example, that glucose is important for both maintenance of meiotic inhibition and ligand-induced maturation [44].

In this study, to model conventional in vitro-maturation protocols, we have taken the alternative approach of looking at the effect of a wide range of doses of FSH on the consumption and production of substrates by spontaneously maturing COCs. Furthermore, previous studies that have examined the effects of FSH on COC metabolism have used COCs from primed mice that have been administered FSH 48 h previously to increase the yield of antral follicles. In contrast, in this study, we have measured substrate production and uptake by individual COCs isolated from the ovaries of unstimulated, prepubertal mice [21], which had not been previously exposed to endogenous or exogenous FSH, and related the maturation status of the oocyte to the metabolism of naive cumulus cells.

This work differs from previous studies on the relationship between COC metabolism and the regulation of meiotic resumption. First, we have analyzed COCs from unprimed mice that have not been exposed to altered levels of FSH in vivo. Second, we have analyzed individual COCs, allowing us unequivocally to relate nutrient uptake and production to resumption and completion of meiosis. Third, we have examined the role of the PI3-kinase pathway in FSH-stimulated glucose uptake and metabolism. Finally, we have used a system to model IVM, where cumulus-enclosed oocytes are allowed to undergo spontaneous maturation in the presence of FSH. We have examined the response of spontaneously maturing COCs to a range of doses of FSH that encompass doses previously used.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Collection of Cumulus-Oocyte Complexes

Unstimulated 25- to 28-day-old F1 (C57BL/6 x CBA/Ca) female mice (Harlan Olac Ltd., Oxon, UK) were killed by cervical dislocation, the ovaries were removed and transferred to M2 medium [45] supplemented with 4 mg/ml bovine serum albumin (BSA, Fraction V; Sigma, Poole, UK). Large antral follicles were punctured with sterile acupuncture needles (AcuMedic, London, UK) to release COCs. Only COCs that consisted of an oocyte surrounded by at least two complete layers of cumulus cells were selected for further culture. Mice were housed and maintained in accordance with the Animals (Scientific Procedures) Act 1986 and associated codes of practice.

In Vitro Maturation of Oocytes

Minimum essential medium (MEM) Eagle (M2279; Sigma) containing 5.55 mM glucose (but no lactate) and supplemented with 0.23 mM sodium pyruvate (Sigma), 3 mg/ml BSA (Sigma), 50 U/ml penicillin, 50 µg/ml streptomycin, and 0.125 µg/ml amphotericin (catalog number 15240–039; GibcoBRL, Paisley, UK) was the basic culture medium used for in vitro maturation (IVM) and measurement of substrate uptake and production. This was supplemented with recombinant FSH (Puregon; Organon, Cambridge, UK) at concentrations of 0, 2, 20, 200, and 2000 ng/ml. One nanogram of Puregon contains 0.01 IU FSH. COCs were taken through four washes of MEM before being cultured individually in 5-µl drops of preequilibrated medium laid down using a positive displacement pipette (SMI digital adjust micropipettor, accuracy ± 1%; Alpha Laboratories, Eastleigh, Hants, UK) and overlaid with silicone oil (Dow Corning 200/ 50cs; BDH, VWR International, Lutterworth, UK) in an atmosphere of 5% CO2 in air at 37°C. The length of incubation was precisely noted and ranged from 15 to 16 h. Similar 5-µl drops of medium alone were incubated alongside the COC-containing drops and served as controls.

Scoring of Nuclear Stage of Maturation

At the end of the culture period, COCs were removed from the drop and the oocyte denuded of cumulus cells by repeated gentle pipetting. Oocytes were scored for stage of nuclear maturation and classified as being at the germinal vesicle (GV) stage if the nuclear membrane remained intact and was clearly visible by light microscopy, metaphase I if there was no visible nuclear membrane, or metaphase II following extrusion of the first polar body (Fig. 1, A—C).



View larger version (46K):
[in this window]
[in a new window]
 
FIG. 1. AC) Light micrographs of mouse oocytes at the germinal vesicle (A), metaphase I (B), and metaphase II (C) stages of nuclear maturation. Original magnification x350. D, E) Negative fluorescence micrographs of chromosome spreads (labeled with DAPI) of (D) a metaphase I oocyte cultured in 20 ng/ml FSH and (E) a metaphase II oocyte matured in 2000 ng/ml FSH. Original magnification x1000. FG) Immunohistochemical localization of GLUT4 (brown) in a paraffin-embedded COC counterstained with hematoxylin (purple) (F) with a control from the same COC where the primary antibody was omitted (G). Original magnification x200. HI) Immunohistochemical localization of GLUT4 (green labeling) in a whole-mounted COC visualized by confocal microscopy (H) with a control where the primary antibody was omitted (I). Cumulus cell nuclei labeled with DAPI appear blue. Original magnification x320

The oocytes were held in similar FSH-containing medium for up to 2 h before preparation for chromosomal analysis, to confirm the stage of nuclear maturation. Oocytes were spread and fixed as described by Tarkowski [46]. Briefly, oocytes were treated with hypotonic solution (1% sodium citrate) for 6–7 min and fixed in 5:1:4 methanol:acetic acid:water for 1 min or until the zona pellucida had disappeared. Oocytes were individually transferred to glass microscope slides and 13 µl of 3:1 methanol:acetic acid fixative was gently dropped onto the oocyte. As the fixative dried, further drops were added; this process was repeated 2–3 times. The oocyte was constantly observed throughout the fixation process using a Leica MZ12 dissecting microscope (Leica Microsystems, Milton Keynes, UK). Slides were dehydrated through an ethanol series (70%, 90%, and 100%; 5 min in each), air dried, and mounted in antifade Vectashield (Vector Laboratories, Peterborough, UK) containing 1.5 µg/ml DAPI (4,6-diamidino-2-phenylindole). Slides were analyzed using a Axioskop fluorescence microscope (Zeiss, Welwyn Garden City, UK) and images captured with a digital camera (Axiophot 2; Zeiss).

Measurement of Pyruvate, Lactate, and Glucose Uptake or Production

Individual 3-µl aliquots of culture medium from the experimental and control incubation drops were diluted with 597 µl of a 5 µM lactate solution (lactate standard; Sigma). All samples were stored at –70°C until analysis. The depletion of pyruvate or glucose and the production of lactate were measured by analyzing the difference between nutrient concentrations in the control and incubation drops as described previously [47].

Briefly, the assay is based on the conversion of substrate to product with the concurrent oxidation of NADH (pyruvate assay), reduction of NAD+ (lactate assay), or reduction of NADP+ (glucose assay) [48]. NADH and NADPH are highly fluorescent; hence, the amount of fluorescence emitted is proportional to the amount of NADH or NADPH present, which in turn is proportional to the amount of substrate in the sample. The fluorescence of the reactions was quantified using a COBAS Bio centrifugal autoanalyzer (Roche Products, Welwyn Garden City, UK) fitted with an FIA option, running assay programs as detailed previously [49]. Reactions were carried out at 25°C. Light of a particular excitation wavelength (340 nm) passes through the reaction mix in multiple cuvettes almost simultaneously, resulting in emission of secondary light, which is detected by a photomultiplier, with signals measured by a photometer. All chemicals were obtained from Boehringer Mannheim (Lewes, UK) unless otherwise stated.

Pyruvate assay Sixty microliters of diluted medium was automatically sampled and added to 200 µl of 50 mM phosphate buffer (30 mM K2HPO4 [BDH] and 20 mM NaH2PO4 [BDH]) containing 10 µM NADH. Ten microliters of lactate dehydrogenase (LDH) (300 IU/mg; 1500 IU/ml) diluted 1:80 with distilled water was added before fluorometric measurement.

Lactate assay Diluted medium (40 µl) was automatically sampled and added to 200 µl buffer containing 0.54 M glycine (Sigma), 0.2 M hydrazine sulphate (Sigma), 2.7 mM EDTA (BDH), 0.54 M NaOH (BDH), and 0.6 mM NAD. Twenty microliters of LDH, diluted 1:10 in distilled water, was added before fluorometric measurement.

Glucose assay Diluted medium (70 µl) was automatically sampled and added to 200 µl buffer containing 82 mM Tris (Sigma), 16.4 mM MgCl2 (BDH), 0.03 mM NADP, and 0.068 mM ATP. Hexokinase/glucose-6-phosphate dehydrogenase (40 µl), diluted 1:80 with distilled water, was added before fluorometric measurement.

Inhibition of PI3-Kinase Pathway with LY294002

The PI3-kinase inhibitor LY294002 (Sigma) was initially solubilized in 100% methanol (BDH, Analar grade) to make a stock of 16.27 mM before storage at –80°C. Mouse cumulus-oocyte complexes were collected and classified as described above. COCs were divided evenly between five treatment groups (Table 1).


View this table:
[in this window]
[in a new window]
 
TABLE 1. Culture conditions for examining the effect of inhibiting the PI-3 kinase pathway using LY294002 on glucose uptake and lactate production by cumulus-oocyte complexes in the presence and absence of FSH

Preincubation COCs were initially preincubated for 30 min in the absence of FSH in medium with and without LY294002 (Table 1). COCs were washed through four drops of MEM supplemented with 0, 10, or 25 µM LY294002, before being individually cultured in 5-µl drops of the same medium overlaid with silicone oil (Dow Corning 200/50cS; BDH) in an atmosphere of 5% CO2 in air at 37°C. Control conditions included medium alone and medium with methanol carrier (Table 1). The concentration of methanol did not exceed 0.33%. At the end of the 30-min preincubation, COCs were moved to fresh drops of medium for overnight incubation with FSH (Puregon; Organon), continuing in the same concentration of LY294002 (see below).

Overnight incubation The culture medium for overnight incubation was supplemented with 2 ng/ml FSH (Puregon; Organon) and 10 or 25 µm LY294002. In addition, three control media contained 1) medium only, 2) medium and methanol carrier alone, and 3) 2 ng/ml FSH and methanol carrier (Table 1). COCs were washed through four washes of the final culture medium before being individually cultured in 5-µl drops of medium overlaid with silicone oil in an atmosphere of 5% CO2 in air at 37°C for 15–16 h. At the end of the culture period, the oocytes were removed from their surrounding cumulus cells and scored for stage of nuclear maturation. Spent culture medium was analyzed for glucose uptake and lactate production as described above.

Immunohistochemical Detection of GLUT4

Mouse COCs, collected as described above, were immediately individually processed for immunohistochemistry. All PBS (Oxoid Ltd., Basingstoke, Hants, UK) was filtered with a 0.22-µm filter (Millipore, Billerica, MA). COCs were fixed with 4% paraformaldehyde (Sigma) (1 h, room temperature) before washing once with PBS. COCs were then individually placed in 2% liquid agarose gel (low gelling temperature, <30°C) (Sigma) and left overnight at room temperature to set. A small section of the gel containing the COC was excised with a scalpel (~5 mm x 5 mm), serially dehydrated through alcohol (Analar; BDH; 70%, 1 h; 90%, 1 h; 100%, 1.5 h) and placed in xylene (Histoclear; National Diagnostics, Hessle, UK) for 1 h. Specimens were embedded in paraffin wax (Surgipath Europe Ltd., Peterborough, UK), serially sectioned (5 µm), and retrieved on poly-L-lysine-coated microscope slides (BDH). Sections were deparaffinized in two changes of xylene (10 min each) and then serially hydrated through alcohol (Analar; BDH; 10 min each 100%, twice; 90%, twice; 70%, twice; and finally, 5 min in distilled water, twice). Mouse skeletal muscle tissue (processed as described above) was used as a positive control.

Slides were examined under an Eclipse TE300 inverted light microscope (Nikon UK, Kingston-upon-Thames, UK) and those containing sections through the COC or muscle were identified. All incubations were carried out in a humidified chamber at ambient temperature (unless otherwise stated). Positive control sections of skeletal muscle were incubated for 15 min with 10 µg/ml pepsin (Sigma) to unmask antigen before processing in parallel with COC-containing slides. Slides were incubated for 15 min in 0.3% hydrogen peroxide (Merck) in water to quench endogenous peroxidase activity, washed with PBS (5 min), incubated with goat-blocking serum (Rabbit Unitect Immunohistochemistry System; Oncogene Research Products, VWR International, Lutterworth, UK) (20 min), washed again with PBS, and then incubated overnight at 4°C with primary rabbit polyclonal antibody to GLUT 4 (Santa Cruz: Sc 7938; Insight Biotechnology Limited, Wembley, UK). Antibodies were used at a dilution of 10 µg/ml (1:20 dilution, as determined by dilution curve) in 1% w/v PBS-BSA (Sigma). Some sections of skeletal muscle and COCs were incubated with rabbit IgG (10 µg/ml; Rabbit Unitect Immunohistochemistry System) in 1% w/v PBS-BSA (Sigma). Sections were rinsed three times in PBS (5 min each) before addition of biotinylated goat anti-rabbit IgG secondary antibody (Rabbit Unitect Immunohistochemistry System), diluted according to the manufacturer's instructions, for 30 min, then washed three times in PBS followed by application of peroxidase-conjugated avidin-biotin complex (Rabbit Unitect Immunohistochemistry System) for 30 min. Sections were washed in five changes of PBS, rinsed in 1% (v/ v) Triton-X 100/PBS (Sigma) (30 sec) and visualized with 3,3'-diaminobenzidine tetrahydrochloride (DAB; 60–90 sec; Zymed Laboratories Inc, San Francisco, CA). Sections were then counterstained with Harris Hematoxylin (BDH) (COCs, 20 sec; skeletal muscle, 2 min). Sections were finally dehydrated through a 70%, 90%, 100% ethanol series as described before and mounted in DPX (BDH).

Sections were examined using an Eclipse E600 light microscope (Nikon UK). Images were captured at the same light intensity using a DXM1200 digital camera (Nikon UK) and Lucia digital image analysis software (Nikon UK).

Confocal Analysis of Whole-Mount COCs

Mouse COCs were collected as described above and immediately processed for immunohistochemistry. COCs were washed in PBS, briefly (1 min) fixed in 100% methanol (BDH, Analar grade) and washed again in PBS. Fixed COCs were then incubated for 30 min in 0.1 M lysine (Sigma) in PBS containing 0.1% Triton-X-100 (Sigma). After three washes in PBS, COCs were transferred into a 10-µl drop of 10% swine-blocking serum (DAKO, Glostrup, Denmark) made up in PBS at room temperature for 30 min. COCs were rinsed in PBS before incubation in 10-µl drops of primary antibody (4 µg/ml; GLUT 4 Santa Cruz: Sc 7938; Insight Biotechnology Ltd.) diluted 1:50 in 1.5% v/v PBS-swine serum (DAKO) overnight at 4°C. After brief washes in PBS, COCs were transferred to 10-µl PBS drops containing a 1:50 dilution of FITC-labeled swine-anti-rabbit secondary antibody (DAKO) and incubated at room temperature for 1 h. Exposure to light was minimized during and following secondary antibody incubation. COCs were washed in PBS before being individually mounted in Vectashield containing 1.5 µg/ml DAPI (Vector Laboratories, Peterborough, UK) on a slide (BDH) within a ring of clear nail varnish (three coats thick). A coverslip was applied and sealed with nail varnish. Slides were examined by laser scanning confocal microscopy using a Leica SP2 laser scanning confocal microscope (Leica Microsystems). The DAPI was stimulated with the 351- and 363-nm laser lines and then the FITC was separately stimulated with 488-nm laser lines to eliminate any bleed through of the emission spectra. Images were stored digitally and reproduced using Adobe Photoshop (Adobe Systems, San Jose, CA).

Statistical Analysis

Numbers of oocytes cultured in all concentrations of FSH that reached metaphase II were compared using {chi}2 analysis for multiple groups. If the difference was significant (P < 0.05), differences between individual pairs of groups were compared using {chi}2 analysis, and the P value was then corrected using the Bonferroni correction (multiplying the P value by the number of comparisons initially made, i.e., n(n – 1)/2, where n is the number of groups). These analyses were performed using GraphPad InStat version 3.0a for Macintosh (GraphPad Software, San Diego, CA; http://www.graphpad.com).

The uptake and/or production of pyruvate, glucose, and lactate by COCs at all concentrations of FSH were found to be normally distributed (using the Kolmogorov-Smirnov test) for oocytes that reached metaphase I or metaphase II. However, the standard deviations (SDs) were not the same in all of the groups (tested using the Bartlett test). The presence of negative values, indicating substrate production rather than uptake, precluded log or reciprocal transformation of the data, so analysis of variance was not appropriate. The data were therefore analyzed using the regression command in STATA 8 (STATA Corporation, College Station, TX). Inspection of raw data showed that the relationships between the dose of FSH and substrate uptake and/or production were not linear, leading us to treat the response to increasing doses of FSH as categorical data. Robust variance estimates were used to allow for the significantly different SDs described earlier; these were calculated using the robust option in STATA 8. Initially, regression of substrate uptake and/or production against dose of FSH was carried out independently for each stage. A regression of substrate uptake and/or production was then carried out against both dose of FSH, stage of maturation reached, and interaction terms, which allowed us to examine whether the COCs where the oocyte reached metaphase II responded to FSH differently from the COCs where the oocyte only reached metaphase I. Finally, the dependence of glucose and lactate uptake on the dose of LY294002 was analyzed using ordinary linear regression (treating dose as a continuous variable). Again, the calculations were performed in STATA 8 with the regression command and the robust option.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Effect of FSH on Nuclear Maturation

A total of 352 COCs (constituting 18 replicate experiments) from 61 mice were matured in vitro, with between 69 and 72 COCs being cultured in each concentration of FSH for 15–16 h overnight. At the end of the incubation, culture medium was retained for analysis of substrate concentration (see below), and oocytes were immediately denuded to determine their maturation status. In a preliminary study, COCs were immediately denuded following isolation from the ovary and all oocytes were confirmed to be at the GV stage.

Incubation with FSH significantly increased the percentage of oocytes that reached metaphase II by the end of the incubation (P = 0.012, {chi}2 for multiple groups, GV/Met I vs. Met II; Fig. 2).



View larger version (26K):
[in this window]
[in a new window]
 
FIG. 2. Effect of increasing FSH concentration on oocyte maturation in vitro. Overall percentage of COCs where the enclosed oocyte had remained at the germinal vesicle stage (white bars), matured to metaphase I (diagonal bars), or completed maturation to metaphase II (black bars) (P = 0.012, {chi}2 for multiple groups)

In the hour following denuding, an additional 29 oocytes, which had not extruded their first polar body at the time of denuding, reached metaphase II. There was no significant difference in the length of time between denuding and spreading of oocytes matured at each dose of FSH (P = 0.99, ANOVA). By the time the oocytes were spread, a similar proportion of oocytes had reached metaphase II irrespective of the dose of FSH (73%, 79%, 80%, 76%, and 78% at 0, 2, 20, 200, and 2000 ng/ml FSH, respectively). The majority of oocytes that completed maturation after denuding had been cultured in the absence of or in low concentrations of FSH. The difference between the maturation rate observed at the time of denuding and when the oocytes were spread, on average 1 h later, suggests that high concentrations of FSH could result in faster maturation. However, a similar proportion of oocytes will ultimately complete maturation irrespective of the presence or dose of FSH, given sufficient time.

All oocytes scored as Met I by light microscopy were confirmed to be Met I by examination of the configuration of chromosomes following spreading (Fig. 1, D and E).

Uptake and Production of Pyruvate, Glucose, and Lactate

Metabolic studies were performed on 14 replicates (274 COCs). COCs where the oocyte completed nuclear maturation and reached metaphase II are termed Met II COCs (n = 194), while COCs where the oocyte failed to complete maturation and only reached metaphase I are termed Met I COCs (n = 71). Twelve oocytes failed to resume meiosis and remained at the GV stage.

FSH had a significant overall effect on the uptake or production of pyruvate (P = 0.0002), glucose (P = 0.0009), and lactate (P < 0.0001) by Met II COCs (Fig. 3). At all concentrations of FSH, glucose uptake and lactate production by Met II COCs were significantly higher compared with control (0 ng/ml; Fig. 3). However, within this range of FSH concentrations, there was a marked lack of any dose effect and the effect of FSH on glucose uptake (P = 0.6) or lactate production (P = 0.7) by Met II COCs was not dose dependent (Fig. 3). Pyruvate uptake and production was also significantly influenced by FSH (P = 0.0002); under control culture conditions, pyruvate was taken up by Met II COCs at a rate of 4.5 ± 2.1 pmols COC–1 h–1. However, in the presence of FSH, Met II COCs produced pyruvate (Fig. 3). At higher concentrations of FSH (200 and 2000 ng/ml), there were significant amounts of pyruvate produced compared with control (P = 0.00003 and P = 0.02, respectively) (Fig. 3).



View larger version (24K):
[in this window]
[in a new window]
 
FIG. 3. Effect of increasing FSH concentration on pyruvate, glucose and lactate uptake or production by individual COCs, where the enclosed oocyte remained at the GV stage (white bars, n = 3–4), matured to metaphase I (diagonal bars, Met I COC; n = 12–18), or completed maturation to metaphase II (black bars, Met II COC; n = 32–44) by the end of the culture period. Bars with asterisks differ significantly from 0 ng/ml FSH (* P < 0.05; ** P < 0.001; *** P < 0.0001). Lactate production by Met I COCs differed significantly from Met II COCs at 20 (P = 0.005) and 200 and 2000 (P < 0.0001) ng/ml FSH. Pyruvate uptake/production by Met I COCs differed significantly from Met II COCs at 200 and 2000 ng/ml FSH (P < 0.0001). Values are means ± SEM

In Met I COCs, in marked contrast with Met II COCs, FSH had no effect on pyruvate uptake/production (P = 0.39), glucose uptake (P = 0.84), or lactate production (P = 0.39). Indeed, Met I COCs had a different metabolic profile from Met II COCs (Fig. 3). Overall, Met II COCs had higher pyruvate production, glucose uptake, and lactate production than Met I COCs at the same concentration of FSH (pyruvate, P < 0.0001; glucose, P = 0.009; lactate, P < 0.0001). Specifically, in the absence of and at 2 ng/ ml FSH, there was no significant difference between Met I COCs and Met II COCs in substrate uptake and production. However, at higher concentrations of FSH, Met II COCs produced significantly more lactate than Met I COCs at 20 (P = 0.004), 200, and 2000 (P < 0.0001) ng/ml FSH. Similarly, Met II COCs produced significantly more pyruvate than Met I COCs at 200 (P = 0.005) and 2000 (P < 0.0001) ng/ml FSH.

Of the 274 COCs that were analyzed for substrate uptake or production, 71 contained an oocyte that had only reached metaphase 1 by the end of the culture. A proportion of these oocytes (15/71, 21%) completed maturation to metaphase II within 1 h 30 min of denuding, before being spread for chromosome analysis. Considering only COCs cultured in the presence of FSH (pooling data from 2 to 2000 ng/ml FSH), those that contained oocytes that matured after denuding produced twice as much lactate as COCs that contained oocytes that did not mature further (65.8 ± 12.7 pmol COC–1 h–1 compared with 30.1 ± 4.4 pmol COC–1 h–1; P = 0.02) (Fig. 4). Further linear regression analysis, taking account of both the stage of meiotic maturation and the dose, showed that the group that completed maturation after denuding had significantly different (P < 0.01) uptake/production of all three substrates compared with both those that had already matured by the time of denuding and those that never progressed beyond metaphase I.



View larger version (20K):
[in this window]
[in a new window]
 
FIG. 4. Pyruvate, glucose, and lactate uptake or production by individual COCs cultured in the presence of 2–2000 ng/ml FSH, where the enclosed oocyte reached metaphase II by the end of the 16-h culture period (black bars, n = 162), reached metaphase I by the end of the culture period, and then subsequently completed maturation within a further 1 h 30 min (diagonal bars, n = 10) and did not progress beyond metaphase I during the culture or the subsequent 1 h 30 min holding period (white bars, Met I COCs, n = 43). The COCs shown are the same as those illustrated in Figure 3. Bars with asterisks differ significantly from Met I COCs (* P < 0.05; ** P < 0.01; *** P < 0.001). Values are means ± SEM

Expression of GLUT4 in Granulosa Cells

Immunohistochemistry of GLUT4, using either a biotinylated secondary antibody in paraffin sections of COCs (Fig. 1, F and G) or a fluorescently labeled secondary antibody in whole mount COCs (Fig. 1, H and I), demonstrated the presence of GLUT4 in the granulosa cells of COCs enclosing a GV-stage oocyte.

Effect of LY294002 on Nuclear Maturation

A total of 136 COCs (constituting seven replicate experiments) from 34 mice were matured in vitro, with between 26 and 28 COCs being cultured under each condition for 15–16 h overnight. At the end of the incubation, culture medium was retained for analysis of substrate concentration (see below), and oocytes were immediately denuded by gentle pipetting to determine their maturation status. The conditions under which the oocytes matured had a significant effect on the proportion of oocytes that reached metaphase II (P = 0.021, {chi}2 for multiple groups, GV/Met I vs. Met II; Fig. 5). However, pairwise comparison showed that LY294002 had no significant effect on maturation (maturation in the presence of methanol carrier and 2 ng/ml FSH against the same media with 10 or 25 µM LY294002, P = 1 and 0.8, respectively, Bonferroni corrected).



View larger version (19K):
[in this window]
[in a new window]
 
FIG. 5. Effect of LY294002 (10 or 25 µM) on oocyte maturation in vitro in the absence and presence (2 ng/ml) of FSH. Table 1 provides detail of the five treatment groups. Overall percentage of COCs where the enclosed oocyte had remained at the germinal vesicle stage (white bars) and matured to metaphase I (diagonal bars) or completed maturation to metaphase II (black bars) (P = 0.021, {chi}2 for multiple groups). Significantly fewer oocytes reached metaphase II in the presence of 10 µM LY294002 than in medium alone (P = 0.02, Fishers exact test with Bonferroni correction) or in the presence of 25µM LY294002 (P = 0.009)

Effect of LY294002 on Uptake and Production of Glucose and Lactate

Metabolic studies were performed for all seven replicates (134 COCs: data for two Met 1 COCs not available). COCs where the oocyte completed nuclear maturation and reached metaphase II are termed Met II COCs (n = 90), while COCs where the oocyte failed to complete maturation and only reached metaphase I are termed Met I COCs (n = 38). Five oocytes failed to resume meiosis and remained at the GV stage and one oocyte had degenerated by the end of the culture period.

Glucose uptake by Met II COCs was similar under control conditions and in the presence of the methanol carrier (P = 0.9; two-tailed unpaired t-test) (Fig. 6) and was comparable with glucose uptake by the control group in the study described above (Fig. 3). Glucose uptake was again significantly increased above control values in the presence of 2 ng/ml FSH and the methanol control (P = 0.001, t-test). LY294002 significantly reduced FSH-stimulated glucose uptake in a dose-dependent manner (P = 0.02, linear regression) to the extent that glucose uptake in the presence of 25 µM LY294002 was similar to control levels, i.e., in the absence of FSH (P = 0.32, t-test) (Fig. 6).



View larger version (42K):
[in this window]
[in a new window]
 
FIG. 6. Effect of LY294002 (10 or 25 µM) on glucose uptake and lactate production by individual COCs (n = 10–23) cultured in the absence and presence (2 ng/ml) of FSH. The enclosed oocyte had completed maturation to metaphase II by the end of the culture period. Table 1 provides detail of the five treatment groups. Bars with the same letter differ significantly from each other. (Glucose: a, P = 0.001; b, P = 0.02. Lactate: c, P = 0.001; d, P = 0.0001). Values are means ± SEM

Lactate production by Met II COCs was also similar under control conditions and in the presence of the methanol carrier (P = 0.62, two-tailed unpaired t-test) (Fig. 6) and was comparable with lactate production by the control group in the study described earlier (Fig. 3). Lactate production was significantly increased above control values in the presence of 2 ng/ml FSH and the methanol carrier (P = 0.001, t-test). As seen for glucose uptake, LY294002 reduced lactate production in a dose-dependent manner, although this trend was not significant (P = 0.15, linear regression) (Fig. 6). Furthermore, lactate production remained significantly higher than controls in the presence of 25 µM LY294002 (P = 0.0001) (Fig. 6).


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The present study describes the uptake and production of glucose, pyruvate, and lactate by individual mouse cumulus-oocyte complexes from unprimed, immature mice as the oocyte undergoes spontaneous nuclear maturation in vitro. Significantly more oocytes resumed and completed nuclear maturation when COCs were exposed in vitro to FSH (Fig. 2). The metabolism of individual COCs at this time was significantly influenced by both the inclusion of FSH in the culture media and the stage of nuclear maturation of the oocyte. FSH, at all of the concentrations tested, increased glucose uptake and lactate production two- to threefold by COCs containing an oocyte that had completed nuclear maturation (Met II COCs) but had no effect on the glucose consumption and lactate production of COCs containing an oocyte that had either begun to mature (Met I COCs) or that remained at the germinal vesicle (GV) stage (Fig. 3). Similarly, in the presence of FSH, Met II COCs produced pyruvate, whereas COCs containing a metaphase I or GV-stage oocyte continued to take up pyruvate at a rate similar to controls. FSH-stimulated glucose uptake by Met II COCs could be abrogated by the PI3-kinase pathway inhibitor LY294002, suggesting that FSH-stimulated glucose uptake is mediated by PI3-kinase activity.

In the absence of FSH, 57% of COCs in this study completed spontaneous maturation within 16 h, whereas a previous study showed higher spontaneous maturation rates (70–80%) in medium containing identical substrate concentrations [19]. In contrast with our results, the latter study [19] and others [16, 20], found that further supplementation of the medium with FSH did not increase maturation rates. The COCs from our study were, however, from unprimed immature mice, whereas all of the previous studies used mice that had been exposed to FSH in vivo before COC collection. Such priming, known to increase both antral follicle size and the developmental capacity of maturing oocytes [21], may be responsible for the higher control maturation rates and the absence of any further augmentation of maturation following exposure to FSH in vitro. It is possible that treating animals with FSH 48 h before retrieval of COCs primes the oocyte for maturation, perhaps by upregulating FSH-receptor expression in the cumulus cells [50], so that the COCs respond more rapidly to FSH in vitro.

Here we showed that FSH at doses of 20 ng/ml or higher significantly increased the proportion of oocytes reaching metaphase II after 15–16 h culture. However, when the oocytes were scored an hour later, a similar proportion of oocytes had completed maturation under all conditions, irrespective of the dose of FSH. This strongly suggests that FSH, at doses of 20 ng/ml or higher, accelerates maturation.

The mechanism by which FSH accelerates maturation is unclear. Gonadotropins are known to stimulate glucose consumption by cumulus cells, leading to pyruvate production [51, 52]. In the mouse, an FSH-stimulated increase in glycolysis, resulting in increased pyruvate production, was thought to be responsible for the increase in spontaneous meiotic maturation seen when glucose was the only available energy source [19]. An additional mechanism by which FSH action and glucose metabolism might interact to regulate meiosis unfolded from an elegant series of studies carried out by Downs and coworkers [24, 43, 53]. Glucose is required for FSH-induced maturation [44]. FSH increases hexokinase activity in the cumulus oophorus [43], facilitating glucose uptake and its conversion to glucose-6-phosphate. Furthermore, it is the pentose phosphate pathway, and not glycolysis, that is the metabolic route that mediates ligand-induced resumption of meiosis [24, 43]. The pentose phosphate pathway provides precursors for the de novo purine pathway, which in turn is involved in meiotic induction [53]. Alternatively, as has recently been shown, ATP induces Ca2+ release from intracellular stores in cumulus cells, which is then transmitted via gap junctions to the oocyte [54]. While FSH itself had no effect on Ca2+ in COCs, it may be that, in our study, the FSH-induced increased glucose uptake resulted in increased glycolytically produced ATP, leading to Ca2+ release and a stimulation of maturation.

In the current study, FSH stimulated glucose consumption and lactate and pyruvate production (and hence glycolysis) by spontaneously maturing individually cultured COCs in a manner similar to group cultured complexes undergoing ligand (FSH)-induced maturation [25, 43]. The significantly higher production of pyruvate at 200 and 2000 ng/ml FSH, with no concomitant increase in glucose uptake (Fig. 3), suggests that glucose could be being diverted to the glycolytic pathway. While the exact fate of the glucose consumed by COCs could not be ascertained, there was a significant correlation (P < 0.0001) between glucose uptake and both pyruvate and lactate production by individual COCs, suggesting that the glucose consumed in this instance was being metabolized, via glycolysis, to pyruvate, which is then converted to lactate, as has been observed previously [25].

While the presence of FSH had a significant effect on the rate of glucose consumption or lactate production, the dose of FSH was immaterial, suggesting that there is a threshold level of less than 2 ng/ml for FSH-induced glucose uptake. Glucose enters cells via facilitated glucose transporters (GLUT transporters), and we have detected the insulin-sensitive transporter GLUT4 in cumulus cells by immunohistochemistry. The lack of dose effect of FSH on glucose uptake is most likely to be caused by saturation of these transporters at the lowest dose of FSH (2 ng/ml). In contrast, pyruvate metabolism did appear to be influenced by the dose of FSH, with a significant increase in pyruvate production seen when COCs were exposed to 200 and 2000 ng/ml FSH. Thus, high levels of FSH appear to alter the nutritional environment of the oocyte by making more pyruvate available.

Culture of individual COCs allows direct and unequivocal comparison between complexes containing oocytes at the same stage of nuclear maturation. Glucose uptake and lactate production are highest when COCs are both exposed to FSH and contain a metaphase II oocyte at the end of culture. Cumulus cells take up most of the glucose; oocytes alone have low or undetectable glycolytic activity [24, 52, 55], so the differences in glucose uptake with maturational stage of the enclosed oocyte are unlikely to be due to changing metabolism of the maturing oocyte itself. Recently, a relationship between pyruvate utilization by COCs and the nuclear stage of the oocyte has been reported, with shifts in uptake and production of pyruvate being observed in group-cultured COCs at specific time points throughout oocyte maturation [25, 56]. Here we have shown that, in the presence of FSH, COCs containing immature oocytes consume pyruvate, while those where the oocyte completed maturation produce pyruvate, consume more glucose, and produce more lactate. The increased glycolysis seen in COCs where the oocyte has completed maturation may well result from the changing energy requirements of the oocyte as it undergoes extensive chromatin and cytoplasmic remodeling during nuclear maturation [57].

It is well established that a dialogue between the oocyte and surrounding somatic cells is necessary for successful follicle development [5861], and the different metabolic patterns seen raise the possibility that a similar dialogue is taking place here, with either the cumulus cells directing maturation or the oocyte directing cumulus cell metabolism. The latter theory is supported by studies showing that glucose oxidation by the cumulus cells of bovine COCs was significantly decreased following removal of the oocyte [52]. The increase in glucose uptake by complexes that have completed nuclear maturation in the presence of FSH suggests that COCs containing a mature oocyte are more able to respond to FSH. Conversely, we must also consider the possibility that a reduced response to FSH by complexes containing an oocyte that fails to mature may simply be a reflection of COC health, with the COC having been isolated from an atretic follicle. However, a proportion of oocytes went on to complete nuclear maturation after denuding, and these oocytes resided in complexes that had a different metabolic profile from those that contained an oocyte that failed to mature (Fig. 4). These findings strengthen the hypothesis that substrate metabolism of the cumulus-oocyte complex is in some way related to meiotic maturation of the oocyte.

A major hormonal regulator of glucose uptake is insulin, which controls glucose uptake by modulating the partitioning of the insulin-sensitive facilitative glucose transporter GLUT4 within the cell [62]. Insulin stimulates the translocation of GLUT4 from intracellular stores to the membrane, hence increasing glucose uptake, and it is well established that this stimulation is mediated by the PI3-kinase pathway [6365]. The observation that FSH can act in a similar manner in stimulating glucose uptake led us to examine whether FSH action was also mediated by the PI3-kinase pathway.

Using immunohistochemistry, we have demonstrated that GLUT4 is present in murine granulosa cells. Previous studies that have examined GLUT expression have produced conflicting results: GLUT4 expression has been detected by Northern blotting in sheep granulosa cells [66], but not in immature mouse [67] or rat [68] granulosa cells, using in situ hybridization or Western analysis, respectively. These variable results may be due to differences in methodology. Recently, we have demonstrated the presence of GLUT4 mRNA in human granulosa-lutein cells using reverse transcription-polymerase chain reaction, with sequence verification of the product (S. Rice, personal communication).

Incubation of FSH-stimulated mouse COCs in the PI3-kinase inhibitor LY294002 significantly decreased glucose uptake in a dose-dependent manner (Fig. 6), suggesting that FSH regulates glucose uptake via the PI3-kinase pathway. This is a likely scenario: it is now becoming clear that FSH can activate a variety of signaling cascades, including the PI3-kinase pathway. Signalling via the PI3-kinase pathway has been clearly demonstrated in rat granulosa cells by increased phosphorylation of protein kinase B (PKB/Akt) by FSH [69, 70]. Furthermore, FSH-stimulated cellular responses can by inhibited by PI3-kinase inhibitors [70, 71]. Our observations of GLUT4 protein in the granulosa cells (Fig. 1), coupled with the inhibition of FSH-stimulated glucose uptake by LY294002 in the intact COC (Fig. 6), suggests that FSH could activate the PI3-kinase pathway, resulting in translocation of GLUT4 to the granulosa cell membranes with a concomitant increase in glucose uptake.

Increased glycolytic activity by feline and bovine oocytes following IVM and before fertilization has been associated with improved preimplantation development [72, 73]. The ability of somatic cells to respond to FSH by increasing their glucose uptake and its subsequent metabolism may be an important factor not only in nuclear maturation, but may also significantly affect cytoplasmic maturation and subsequent preimplantation development, an important aspect of which must be the activation of metabolic pathways for the production of energy and the accumulation of the precursors of biosynthesis.

Here we have shown that FSH stimulates glucose uptake and pyruvate and lactate production in spontaneously maturing oocytes. The lack of a dose effect of FSH on glucose uptake suggests that only low physiological doses of FSH are required during IVM. FSH increases glucose uptake by activating the PI3-kinase pathway, and the presence of GLUT4 in the granulosa cells suggests a likely candidate for mediating this effect. High doses of FSH change the environment of the maturing oocyte by increasing pyruvate production by cumulus cells. Increased glucose uptake may be involved in the higher levels of maturation seen in high FSH concentrations, although whether this is regulated by increased availability of pyruvate, increased activity of the pentose phosphate pathway, or higher ATP levels remains unclear. Further studies are required to precisely evaluate the nature of the dialogue between the maturing oocyte and the surrounding cumulus cells in terms of changing FSH responsiveness and nutrient metabolism and to identify whether the cumulus cells or the oocyte directs this dialogue.


    FOOTNOTES
 
1 Supported by Wellbeing. Back

2 Correspondence: Kate Hardy, Institute of Reproductive and Developmental Biology, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK. FAX: 44 0 207 594 2111; k.hardy{at}imperial.ac.uk Back

Received: 23 September 2003.

First decision: 2 October 2003.

Accepted: 3 March 2004.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Hillier SG. Gonadotropic control of ovarian follicular growth and development. Mol Cell Endocrinol 2001 179:39-46[CrossRef][Medline]
  2. Camp TA, Rahal JO, Mayo KE. Cellular localization and hormonal regulation of follicle-stimulating hormone and luteinizing hormone receptor messenger RNAs in the rat ovary. Mol Endocrinol 1991 5:1405-1417[CrossRef][Medline]
  3. Dierich A, Sairam MR, Monaco L, Fimia GM, Gansmuller A, LeMeur M, Sassone-Corsi P. Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci U S A 1998 95:13612-13617[Abstract/Free Full Text]
  4. Themmen APN, Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 2000 21:551-583[Abstract/Free Full Text]
  5. Dekel N, Beers WH. Rat oocyte maturation in vitro: relief of cyclic AMP inhibition by gonadotropins. Proc Natl Acad Sci U S A 1978 75:4369-4373[Abstract/Free Full Text]
  6. Downs SM, Daniel SA, Eppig JJ. Induction of maturation in cumulus cell-enclosed mouse oocytes by follicle-stimulating hormone and epidermal growth factor: evidence for a positive stimulus of somatic cell origin. J Exp Zool 1988 245:86-96[CrossRef][Medline]
  7. Singh B, Meng L, Rutledge JM, Armstrong DT. Effects of epidermal growth factor and follicle-stimulating hormone during in vitro maturation on cytoplasmic maturation of porcine oocytes. Mol Reprod Dev 1997 46:401-407[CrossRef][Medline]
  8. Pincus GP, Enzmann EV. The comparative behaviour of mammalian eggs in vivo and in vitro. I. The activation of ovarian eggs. J Exp Med 1935 62:665-675[Abstract]
  9. Edwards RG. Maturation in vitro of mouse, sheep, cow, pig, rhesus monkey and human ovarian oocytes. Nature 1965 208:349-351[CrossRef][Medline]
  10. Trounson A, Anderiesz C, Jones G. Maturation of human oocytes in vitro and their developmental competence. Reproduction 2001 121:51-75[Abstract]
  11. Rizos D, Ward F, Duffy P, Boland MP, Lonergan P. Consequences of bovine oocyte maturation, fertilization or early embryo development in vitro versus in vivo: implications for blastocyst yield and blastocyst quality. Mol Reprod Dev 2002 61:234-248[CrossRef][Medline]
  12. Hardy K, Wright CS, Franks S, Winston RM. In vitro maturation of oocytes. Br Med Bull 2000 56:588-602[Abstract/Free Full Text]
  13. Bevers MM, Dieleman SJ, van den Hurk R, Izadyar F. Regulation and modulation of oocyte maturation in the bovine. Theriogenology 1996 47:13-22
  14. Jinno M, Sandow BA, Iizuka R, Hodgen GD. Full physiological maturation in vitro of immature mouse oocytes induced by sequential treatment with follicle-stimulating hormone and luteinizing hormone. J In Vitro Fert Embryo Transf 1990 7:285-291[CrossRef][Medline]
  15. Zhang X, Armstrong DT. Effects of follicle-stimulating hormone and ovarian steroids during in vitro meiotic maturation on fertilization of rat oocytes. Gamete Res 1989 23:267-277[CrossRef][Medline]
  16. Merriman JA, Whittingham DG, Carroll J. The effect of follicle stimulating hormone and epidermal growth factor on the developmental capacity of in vitro matured mouse oocytes. Hum Reprod 1998 13:690-695[Abstract/Free Full Text]
  17. Izadyar F, Zeinstra E, Bevers MM. Follicle-stimulating hormone and growth hormone act differently on nuclear maturation while both enhance developmental competence of in vitro matured bovine oocytes. Mol Reprod Dev 1998 51:339-345[CrossRef][Medline]
  18. Schoevers EJ, Kidson A, Verheijden JH, Bevers MM. Effect of follicle-stimulating hormone on nuclear and cytoplasmic maturation of sow oocytes in vitro. Theriogenology 2003 59:2017-2028[CrossRef][Medline]
  19. Downs SM, Hudson ED. Energy substrates and the completion of spontaneous meiotic maturation. Zygote 2000 8:339-351[CrossRef][Medline]
  20. Anderiesz C, Ferraretti A, Magli C, Fiorentino A, Fortini D, Gianaroli L, Jones GM, Trounson AO. Effect of recombinant human gonadotrophins on human, bovine and murine oocyte meiosis, fertilization and embryonic development in vitro. Hum Reprod 2000 15:1140-1148[Abstract/Free Full Text]
  21. Eppig JJ, Schroeder AC, O'Brien MJ. Developmental capacity of mouse oocytes matured in vitro: effects of gonadotrophic stimulation, follicular origin and oocyte size. J Reprod Fertil 1992 95:119-127[Abstract/Free Full Text]
  22. Moor RM, Osborn JC, Crosby IM. Gonadotrophin-induced abnormalities in sheep oocytes after superovulation. J Reprod Fertil 1985 74:167-172[Abstract/Free Full Text]
  23. Szoltys M, Galas J, Jablonka A, Tabarowski Z. Some morphological and hormonal aspects of ovulation and superovulation in the rat. J Endocrinol 1994 141:91-100[Abstract/Free Full Text]
  24. Downs SM, Utecht AM. Metabolism of radiolabeled glucose by mouse oocytes and oocyte-cumulus cell complexes. Biol Reprod 1999 60:1446-1452[Abstract/Free Full Text]
  25. Downs SM, Humpherson PG, Leese HJ. Pyruvate utilization by mouse oocytes is influenced by meiotic status and the cumulus oophorus. Mol Reprod Dev 2002 62:113-123[CrossRef][Medline]
  26. Eppig JJ. Gonadotropin stimulation of the expansion of cumulus oophori isolated from mice: general conditions for expansion in vitro. J Exp Zool 1979 208:111-120[CrossRef][Medline]
  27. Beaumont HM, Smith AF. Embryonic mortality during the pre- and postimplantation periods of pregnancy in mature mice after superovulation. J Reprod Fertil 1975 45:437-448[Abstract/Free Full Text]
  28. Fraser LR. Fertilization and preimplantation development in vitro of mouse eggs obtained following stimulation with different doses of pregnant mare serum: a comparison of the responses in two strains. Differentiation 1977 9:29-35[CrossRef][Medline]
  29. Blondin P, Coenen K, Guilbault LA, Sirard M-A. Superovulation can reduce the developmental competence of bovine embryos. Theriogenology 1996 46:1191-1203
  30. Ertzeid G, Storeng R. Adverse effects of gonadotrophin treatment on pre- and postimplantation development in mice. J Reprod Fertil 1992 96:649-655[Abstract/Free Full Text]
  31. Elbling L. Does gonadotrophin-induced ovulation in mice cause malformations in the offspring?. Nature 1973 246:37-39[CrossRef][Medline]
  32. Luckett DC, Mukherjee AB. Embryonic characteristics in superovulated mouse strains. Comparative analyses of the incidence of chromosomal aberrations, morphological malformations, and mortality of embryos from two strains of superovulated mice. J Hered 1986 77:39-42[Abstract/Free Full Text]
  33. Sakai N, Endo A. Potential teratogenicity of gonadotropin treatment for ovulation induction in the mouse offspring. Teratology 1987 36:229-233[CrossRef][Medline]
  34. McKiernan SH, Bavister BD. Gonadotrophin stimulation of donor females decreases postimplantation viability of cultured one-cell hamster embryos. Hum Reprod 1998 13:724-729[Abstract/Free Full Text]
  35. Ertzeid G, Storeng R. The impact of ovarian stimulation on implantation and fetal development in mice. Hum Reprod 2001 16:221-225[Abstract/Free Full Text]
  36. Van der Auwera I, D'Hooghe T. Superovulation of female mice delays embryonic and fetal development. Hum Reprod 2001 16:1237-1243[Abstract/Free Full Text]
  37. Biggers JD, Whittingham DG, Donahue RP. The pattern of energy metabolism in the mouse oocyte and zygote. Proc Natl Acad Sci U S A 1967 58:560-567[Free Full Text]
  38. Eppig JJ. Analysis of mouse oogenesis in vitro. Oocyte isolation and the utilization of exogenous energy sources by growing oocytes. J Exp Zool 1976 198:375-382[CrossRef][Medline]
  39. Leese HJ, Barton AM. Production of pyruvate by isolated mouse cumulus cells. J Exp Zool 1985 234:231-236[CrossRef][Medline]
  40. Donahue RP, Stern S. Follicular cell support of oocyte maturation: production of pyruvate in vitro. J Reprod Fertil 1968 17:395-398[Abstract/Free Full Text]
  41. Downs SM, Mastropolo AM. The participation of energy substrates in the control of meiotic maturation in murine oocytes. Dev Biol 1994 162:154-168[CrossRef][Medline]
  42. Rose-Hellekant TA, Libersky-Williamson EA, Bavister BD. Energy substrates and amino acids provided during in vitro maturation of bovine oocytes alter acquisition of developmental competence. Zygote 1998 6:285-294[CrossRef][Medline]
  43. Downs SM, Humpherson PG, Martin KL, Leese HJ. Glucose utilization during gonadotropin-induced meiotic maturation in cumulus cell-enclosed mouse oocytes. Mol Reprod Dev 1996 44:121-131[CrossRef][Medline]
  44. Fagbohun CF, Downs SM. Requirement for glucose in ligand-stimulated meiotic maturation of cumulus cell-enclosed mouse oocytes. J Reprod Fertil 1992 96:681-697[Abstract/Free Full Text]
  45. Whittingham DG. Culture of mouse ova. J Reprod Fertil Suppl 1971 14:7-21[Medline]
  46. Tarkowski AK. An air drying method for chromosome preparation from mouse eggs. Cytogenetics 1966 5:394-400[CrossRef]
  47. Hardy K, Robinson FM, Paraschos T, Wicks R, Franks S, Winston RM. Normal development and metabolic activity of preimplantation embryos in vitro from patients with polycystic ovaries. Hum Reprod 1995 10:2125-2135[Abstract/Free Full Text]
  48. Gardner DK, Leese HJ. Concentrations of nutrients in mouse oviduct fluid and their effects on embryo development and metabolism in vitro. J Reprod Fertil 1990 88:361-368[Abstract/Free Full Text]
  49. Conaghan J. The human preimplantation embryo: assessment of culture conditions and viability. London, UK: University of London; 1996. Thesis
  50. Findlay JK, Drummond AE. Regulation of the FSH receptor in the ovary. Trends Endocrinol Metab 1999 10:183-188[CrossRef][Medline]
  51. Hillier SG, Purohit A, Reichert LE Jr. Control of granulosa cell lactate production by follicle-stimulating hormone and androgen. Endocrinology 1985 116:1163-1167[Abstract]
  52. Zuelke KA, Brackett BG. Effects of luteinizing hormone on glucose metabolism in cumulus-enclosed bovine oocytes matured in vitro. Endocrinology 1992 131:2690-2696[Abstract]
  53. Downs SM, Humpherson PG, Leese HJ. Meiotic induction in cumulus cell-enclosed mouse oocytes: involvement of the pentose phosphate pathway. Biol Reprod 1998 58:1084-1094[Abstract/Free Full Text]
  54. Webb RJ, Bains H, Cruttwell C, Carroll J. Gap-junctional communication in mouse cumulus-oocyte complexes: implications for the mechanism of meiotic maturation. Reproduction 2002 123:41-52[Abstract]
  55. Leese HJ, Barton AM. Pyruvate and glucose uptake by mouse ova and preimplantation embryos. J Reprod Fertil 1984 72:9-13[Abstract/Free Full Text]
  56. Downs SM, Houghton FD, Humpherson PG, Leese HJ. Substrate utilization and maturation of cumulus cell-enclosed mouse oocytes: evidence that pyruvate oxidation does not mediate meiotic induction. J Reprod Fertil 1997 110:1-10[Abstract/Free Full Text]
  57. Albertini DF, Sanfins A, Combelles CM. Origins and manifestations of oocyte maturation competencies. Reprod Biomed Online 2003 6:410-415[Medline]
  58. Eppig JJ. Oocyte control of ovarian follicular development and function in mammals. Reproduction 2001 122:829-838[Abstract]
  59. Eppig JJ, Wigglesworth K, Pendola FL. The mammalian oocyte orchestrates the rate of ovarian follicular development. Proc Natl Acad Sci U S A 2002 99:2890-2894[Abstract/Free Full Text]
  60. Matzuk MM, Burns KH, Viveiros MM, Eppig JJ. Intercellular communication in the mammalian ovary: oocytes carry the conversation. Science 2002 296:2178-2180[Abstract/Free Full Text]
  61. Vanderhyden BC, Macdonald EA. Mouse oocytes regulate granulosa cell steroidogenesis throughout follicular development. Biol Reprod 1998 59:1296-1301[Abstract/Free Full Text]
  62. Watson RT, Pessin JE. Intracellular organization of insulin signaling and GLUT4 translocation. Recent Prog Horm Res 2001 56:175-193[Abstract]
  63. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 1994 14:4902-4911[Abstract/Free Full Text]
  64. Haruta T, Morris AJ, Rose DW, Nelson JG, Mueckler M, Olefsky JM. Insulin-stimulated GLUT4 translocation is mediated by a divergent intracellular signaling pathway. J Biol Chem 1995 270:27991-27994[Abstract/Free Full Text]
  65. Khan AH, Pessin JE. Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. Diabetologia 2002 45:1475-1483[CrossRef][Medline]
  66. Williams SA, Blache D, Martin GB, Foot R, Blackberry MA, Scaramuzzi RJ. Effect of nutritional supplementation on quantities of glucose transporters 1 and 4 in sheep granulosa and theca cells. Reproduction 2001 122:947-956[Abstract]
  67. Zhou J, Bievre M, Bondy CA. Reduced GLUT1 expression in Igf1–/– null oocytes and follicles. Growth Horm IGF Res 2000 10:111-117[CrossRef][Medline]
  68. Kodaman PH, Behrman HR. Hormone-regulated and glucose-sensitive transport of dehydroascorbic acid in immature rat granulosa cells. Endocrinology 1999 140:3659-3665[Abstract/Free Full Text]
  69. Gonzalez-Robayna IJ, Falender AE, Ochsner S, Firestone GL, Richards JS. Follicle-stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-induced kinase (Sgk): evidence for A kinase-independent signaling by FSH in granulosa cells. Mol Endocrinol 2000 14:1283-1300[Abstract/Free Full Text]
  70. Shimada M, Ito J, Yamashita Y, Okazaki T, Isobe N. Phosphatidylinositol 3-kinase in cumulus cells is responsible for both suppression of spontaneous maturation and induction of gonadotropin-stimulated maturation of porcine oocytes. J Endoc